Proteonomix, Inc. (OTCBB: PROT), a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, announced today that it will be presenting at the Investor Summit 2012 on February 1, 2012, sponsored by Merriman Capital at the Intercontinental Time Square Hotel in New York City.
Michael Cohen, President of the Company, stated: “We thank Merriman Capital ...
Continue Reading →
27
JAN
JAN
0
Share
